Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Challenging Diagnosis of Cushing's Syndrome in Primary Care: A Case Report.

Cureus·2026
Same author

Assessment of Peripheral Arterial (Normal) Flows in Multiple Vascular Territories in Patients Receiving Mechanical Cardiac Support.

Journal of cardiovascular echography·2026
Same author

Utilization and Outcomes of Permanent Pacemakers After Bicaval Heart Transplantation: A Large Institutional Experience.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Effect of proprotein convertase subtilisin kexin 9 inhibitors on platelet aggregation in patients with and without diabetes.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

Assessing the "Optimism-Knowledge Gap": An Exploratory Study of AI Awareness, Application, and Educational Needs Among a Sample of Italian Clinicians.

Healthcare (Basel, Switzerland)·2026
Same author

Diffuse Cutaneous Systemic Sclerosis Complicated by Serum Amyloid A Protein Cardiac Amyloidosis and Cardiogenic Shock.

CJC open·2026

Related Experiment Video

Updated: Jan 18, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.0K

The Total Artificial Heart: A Historical Perspective.

Daniele Masarone1, Rita Gravino1, Luigi Falco1

  • 1Department of Cardiology, AORN dei Colli-Monaldi Hospital, 80131 Naples, Italy.

Journal of Clinical Medicine
|September 13, 2025
PubMed
Summary

Developing total artificial hearts (TAHs) aims to bridge patients with advanced biventricular heart failure to transplantation. This review covers TAH history, current devices, and future innovations for life support.

Keywords:
advanced heart failurehistory of medicinetotal artificial heart

More Related Videos

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.9K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.1K

Related Experiment Videos

Last Updated: Jan 18, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.0K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.9K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.1K

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Science
  • Medical Devices

Background:

  • Advanced biventricular heart failure necessitates mechanical circulatory support.
  • Total artificial hearts (TAHs) serve as a bridge to transplantation.
  • Significant progress has been made in TAH technology.

Purpose of the Study:

  • To provide a historical overview of total artificial heart development.
  • To analyze current total artificial heart devices.
  • To discuss future innovations in TAH systems.

Main Methods:

  • Literature review of historical and current total artificial heart research.
  • Analysis of existing total artificial heart device designs and performance.
  • Exploration of emerging technologies and future directions in the field.

Main Results:

  • The evolution of total artificial hearts has progressed significantly.
  • Current devices offer viable solutions for end-stage heart failure.
  • Technological advancements promise improved future TAH systems.

Conclusions:

  • Total artificial hearts are crucial for managing end-stage heart failure.
  • Ongoing innovation is vital for enhancing patient outcomes.
  • Future TAH systems are expected to offer greater reliability and functionality.